Company Sanofi

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 16:55:00 10/12/2025 GMT			After hours 20:59:59
82.68 ^EUR	-0.66%		82.92	+0.29%

04:05pm	InduPro, Inc. announced that it has received funding from Sanofi	CI
12:03pm	Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial	RE

Business description: Sanofi

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (79.8%): prescription drugs in the areas of specialty medicine (63.2% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (36.8%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (20.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.

At the end of 2024, the group had 52 production sites worldwide.

In October 2024, the consumer healthcare products business (Opella) was classified as a discontinued operation.

Net sales are distributed geographically as follows: France (4.4%), Europe (17.6%), the United States (48.7%), China (6.5%) and other (22.8%).

Number of employees: 82,878

Sales by Activity: Sanofi

Fiscal Period: December	2020	2021	2022	2023	2024
Biopharma	-	-	-	41.21B	43.95B
Consumer Healthcare	4.45B	4.52B	5.14B	5.23B	-
Pharmaceuticals Excl. Consumer Healthcare	25.8B	27.23B	31.34B	-	-
Vaccines	7.11B	7.42B	8.9B	-	-
Others	-	-	7M	-	339M

See all business segments

Geographical breakdown of sales: Sanofi

Fiscal Period: December	2020	2021	2022	2023	2024
United States	13.46B	14.38B	18.28B	18.51B	19.99B
Rest of The World	7.76B	7.85B	8.39B	13.46B	12.07B
Europe (Excluding France)	-	-	-	8.01B	7.21B
France	-	-	-	2.38B	1.81B
Europe (Excl. Russia)	9.15B	9.76B	10B	-	-
China	2.45B	2.72B	3.12B	-	-
Russia	641M	575M	674M	-	-
Brazil	836M	815M	927M	-	-
North America (Excluding United States)	-	-	-	704M	-
Japan	1.74B	1.66B	1.61B	-	-

See all geographic segments

Executive Committee: Sanofi

Manager	Title	Age	Since
Paul Hudson CEO	Chief Executive Officer	58	31/08/2019
François-Xavier Roger DFI	Director of Finance/CFO	63	31/03/2024
Madeleine Roach COO	Chief Operating Officer	41	30/09/2023
Houman Ashrafian CTO	Chief Tech/Sci/R&D Officer	50	10/09/2023
Thomas Kudsk Larsen IRC	Investor Relations Contact	51	14/03/2024

See SANOFI governance

Composition of the Board of Directors: Sanofi

Director	Title	Age	Since
Patrick Kron BRD	Director/Board Member	72	30/04/2014
Christophe Babule BRD	Director/Board Member	60	29/04/2019
Paul Hudson BRD	Director/Board Member	58	29/10/2019
Rachel Duan BRD	Director/Board Member	55	27/04/2020
Lise Kingo BRD	Director/Board Member	64	27/04/2020
Barbara Lavernos BRD	Director/Board Member	57	29/04/2021
Wolfgang Laux BRD	Director/Board Member	57	31/03/2021
Carole Ferrand BRD	Director/Board Member	54	02/05/2022
Emile Voest BRD	Director/Board Member	66	02/05/2022
Antoine Yver BRD	Director/Board Member	67	02/05/2022

Composition of the Board of Directors

Shareholders: Sanofi

Name	Equities	%	Valuation
L'ORÉAL 7.224 %	88,670,657	7.224 %	8 825 M €
SANOFI 0.7765 %	9,531,081	0.7765 %	949 M €
OFI Invest Asset Management SA 0.3025 %	3,712,787	0.3025 %	370 M €
State Street Global Advisors Ltd. 0.1378 %	1,691,204	0.1378 %	168 M €
Sjunde AP-fonden 0.1268 %	1,556,065	0.1268 %	155 M €

Name	Equities	%	Valuation
Dodge & Cox 2.808 %	68,931,747	2.808 %	3 438 M €
Fisher Asset Management LLC 0.5124 %	12,578,746	0.5124 %	627 M €
Merrill Lynch International 0.4021 %	9,872,475	0.4021 %	492 M €
Eaton Vance Management 0.308 %	7,561,925	0.308 %	377 M €
Barrow, Hanley, Mewhinney & Strauss LLC 0.2903 %	7,126,993	0.2903 %	355 M €

List of SANOFI shareholders

Holdings: Sanofi

Name	Equities	%	Valuation
SANOFI 0.78%	9,531,081	0.78%	948,616,769 $
SANOFI 60.4%	13,909,587	60.4%	723,225,360 $
SANOFI INDIA LIMITED 60.4%	13,909,587	60.4%	682,988,402 $
EUROAPI 29.6%	28,298,074	29.6%	102,727,668 $
MEIRAGTX HOLDINGS PLC 15.15%	12,197,737	15.15%	101,241,217 $
MEIRAGTX HOLDINGS PLC 7.96%	1,157,926	7.96%	97,404,735 $
NOVAVAX, INC. 4.23%	6,880,481	4.23%	48,507,391 $
ANAPTYSBIO, INC. 2.97%	821,917	2.97%	34,232,843 $
IMMUNEERING CORPORATION 4.19%	2,708,559	4.19%	20,747,562 $
INNATE PHARMA 9.05%	8,345,387	9.05%	16,929,786 $

Company details: Sanofi

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com

Group companies: Sanofi

Name	Category and Sector
SANOFI INDIA LIMITED	Pharmaceuticals: Major
SANOFI INDIA LIMITED	Pharmaceuticals: Major
Sanofi Healthcare India Pvt Ltd. Sanofi Healthcare India Pvt Ltd. BiotechnologyHealth Technology Develops and manufactures vaccines	Biotechnology
Sanofi Aventis Paraguay SA
Sanofi Manufacturing Pte Ltd.

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SANOFI	-0.66%	-4.03%	-9.95%	-6.82%	118B
ELI LILLY AND COMPANY	+1.16%	-3.86%	+24.27%	+170.56%	879B
JOHNSON & JOHNSON	+3.29%	+0.59%	+38.40%	+16.14%	482B
ABBVIE INC.	+0.98%	-2.20%	+28.18%	+36.21%	394B
ROCHE HOLDING AG	+2.12%	+2.78%	+25.19%	+5.71%	335B
ASTRAZENECA PLC	-0.57%	-2.07%	+26.28%	+19.02%	281B
NOVARTIS AG	-1.31%	-0.73%	+17.95%	+23.33%	254B
MERCK & CO., INC.	+0.75%	-4.55%	-3.35%	-10.42%	240B
NOVO NORDISK A/S	+3.31%	+0.67%	-60.49%	-32.93%	207B
AMGEN INC.	+0.49%	-8.70%	+14.37%	+13.95%	169B
Average	+0.98%	-2.70%	+10.09%	+23.48%	335.94B
Weighted average by Cap.	+1.24%	-3.01%	+17.63%	+52.82%